Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-007784
Filing Date
2021-02-24
Accepted
2021-02-24 06:06:16
Documents
76
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 2020 10-K snss-10k_20201231.htm 10-K 2873992
2 EX-4.1 snss-ex41_60.htm EX-4.1 31372
3 EX-21.1 snss-ex211_7.htm EX-21.1 2598
4 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM snss-ex231_10.htm EX-23.1 14885
5 EX-31.1 snss-ex311_6.htm EX-31.1 16534
6 EX-31.2 snss-ex312_8.htm EX-31.2 16322
7 EX-32.1 snss-ex321_9.htm EX-32.1 9383
8 GRAPHIC g4mt13lpp00k000001.jpg GRAPHIC 111239
  Complete submission text file 0001564590-21-007784.txt   8571950

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT snss-20201231.xml EX-101.INS 1542748
10 XBRL TAXONOMY EXTENSION SCHEMA snss-20201231.xsd EX-101.SCH 63462
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20201231_cal.xml EX-101.CAL 55030
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20201231_def.xml EX-101.DEF 171656
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20201231_lab.xml EX-101.LAB 500897
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20201231_pre.xml EX-101.PRE 354150
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 21668378
SIC: 2834 Pharmaceutical Preparations